Liaman Mamedova
Affiliations: | Kansas State University, Manhattan, KS, United States |
Google:
"Liaman Mamedova"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mamedova LK, Wang R, Besada P, et al. (2008) Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 58: 232-9 |
Besada P, Mamedova LK, Palaniappan KK, et al. (2006) NUCLEOSIDE PRODRUGS OF A ADENOSINE RECEPTOR AGONISTS AND ANTAGONISTS. Collection of Czechoslovak Chemical Communications. 71: 912-928 |
Mamedova LK, Gao ZG, Jacobson KA. (2006) Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors. Biochemical Pharmacology. 72: 1031-41 |
Jacobson KA, Costanzi S, Joshi BV, et al. (2006) Agonists and antagonists for P2 receptors. Novartis Foundation Symposium. 276: 58-68; discussion 68 |
Gao ZG, Duong HT, Sonina T, et al. (2006) Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists. Journal of Medicinal Chemistry. 49: 2689-702 |
Besada P, Mamedova LK, Palaniappan KK, et al. (2006) Nucleoside prodrugs of A3 adenosine receptor agonists and antagonists Collection of Czechoslovak Chemical Communications. 71: 912-928 |
Costanzi S, Joshi BV, Maddileti S, et al. (2005) Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference. Journal of Medicinal Chemistry. 48: 8108-11 |
Mamedova L, Capra V, Accomazzo MR, et al. (2005) CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochemical Pharmacology. 71: 115-25 |
Kim YC, Lee JS, Sak K, et al. (2005) Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochemical Pharmacology. 70: 266-74 |
Besada P, Mamedova L, Thomas CJ, et al. (2005) Design and synthesis of new bicyclic diketopiperazines as scaffolds for receptor probes of structurally diverse functionality. Organic & Biomolecular Chemistry. 3: 2016-25 |